![]() |
Volumn 60, Issue 14, 2012, Pages 1295-1296
|
Interferon-beta improves survival in enterovirus-associated cardiomyopathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BETA INTERFERON;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
SPIRONOLACTONE;
CARDIOMYOPATHY;
CAUSE OF DEATH;
CONGESTIVE CARDIOMYOPATHY;
DEFIBRILLATION;
DISEASE ASSOCIATION;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG EFFICACY;
ENTEROVIRUS INFECTION;
HEART FAILURE;
HEART HEMODYNAMICS;
HUMAN;
INTERFERON PRODUCTION;
LETTER;
NONHUMAN;
PERSISTENT VIRUS INFECTION;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
SHORT COURSE THERAPY;
SURVIVAL RATE;
TREATMENT DURATION;
VIRAL CLEARANCE;
ADULT;
ANTIVIRAL AGENTS;
BIOPSY;
CARDIOMYOPATHY, DILATED;
COHORT STUDIES;
ENTEROVIRUS;
ENTEROVIRUS INFECTIONS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTERFERON-BETA;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
EID: 84866691571
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2012.06.026 Document Type: Letter |
Times cited : (121)
|
References (5)
|